1 Spine Osteoarthritis Pain Medicine Market Overview 1.1 Product Overview and Scope of Spine Osteoarthritis Pain Medicine 1.2 Spine Osteoarthritis Pain Medicine Segment by Type 1.2.1 Global Spine Osteoarthritis Pain Medicine Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Oral 1.2.3 Injection 1.2.4 External 1.3 Spine Osteoarthritis Pain Medicine Segment by Application 1.3.1 Global Spine Osteoarthritis Pain Medicine Sales Comparison by Application: (2021-2027) 1.3.2 Medical Care 1.3.3 Personal Care 1.4 Global Spine Osteoarthritis Pain Medicine Market Size Estimates and Forecasts 1.4.1 Global Spine Osteoarthritis Pain Medicine Revenue 2016-2027 1.4.2 Global Spine Osteoarthritis Pain Medicine Sales 2016-2027 1.4.3 Spine Osteoarthritis Pain Medicine Market Size by Region: 2016 Versus 2021 Versus 2027 2 Spine Osteoarthritis Pain Medicine Market Competition by Manufacturers 2.1 Global Spine Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2016-2021) 2.2 Global Spine Osteoarthritis Pain Medicine Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Spine Osteoarthritis Pain Medicine Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Spine Osteoarthritis Pain Medicine Manufacturing Sites, Area Served, Product Type 2.5 Spine Osteoarthritis Pain Medicine Market Competitive Situation and Trends 2.5.1 Spine Osteoarthritis Pain Medicine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Spine Osteoarthritis Pain Medicine Players Market Share by Revenue 2.5.3 Global Spine Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Spine Osteoarthritis Pain Medicine Retrospective Market Scenario by Region 3.1 Global Spine Osteoarthritis Pain Medicine Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Spine Osteoarthritis Pain Medicine Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Spine Osteoarthritis Pain Medicine Market Facts & Figures by Country 3.3.1 North America Spine Osteoarthritis Pain Medicine Sales by Country 3.3.2 North America Spine Osteoarthritis Pain Medicine Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Spine Osteoarthritis Pain Medicine Market Facts & Figures by Country 3.4.1 Europe Spine Osteoarthritis Pain Medicine Sales by Country 3.4.2 Europe Spine Osteoarthritis Pain Medicine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Spine Osteoarthritis Pain Medicine Market Facts & Figures by Region 3.5.1 Asia Pacific Spine Osteoarthritis Pain Medicine Sales by Region 3.5.2 Asia Pacific Spine Osteoarthritis Pain Medicine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Spine Osteoarthritis Pain Medicine Market Facts & Figures by Country 3.6.1 Latin America Spine Osteoarthritis Pain Medicine Sales by Country 3.6.2 Latin America Spine Osteoarthritis Pain Medicine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Spine Osteoarthritis Pain Medicine Market Facts & Figures by Country 3.7.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Country 3.7.2 Middle East and Africa Spine Osteoarthritis Pain Medicine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Spine Osteoarthritis Pain Medicine Historic Market Analysis by Type 4.1 Global Spine Osteoarthritis Pain Medicine Sales Market Share by Type (2016-2021) 4.2 Global Spine Osteoarthritis Pain Medicine Revenue Market Share by Type (2016-2021) 4.3 Global Spine Osteoarthritis Pain Medicine Price by Type (2016-2021) 5 Global Spine Osteoarthritis Pain Medicine Historic Market Analysis by Application 5.1 Global Spine Osteoarthritis Pain Medicine Sales Market Share by Application (2016-2021) 5.2 Global Spine Osteoarthritis Pain Medicine Revenue Market Share by Application (2016-2021) 5.3 Global Spine Osteoarthritis Pain Medicine Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Spine Osteoarthritis Pain Medicine Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Johnson and Johnson 6.2.1 Johnson and Johnson Corporation Information 6.2.2 Johnson and Johnson Description and Business Overview 6.2.3 Johnson and Johnson Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Johnson and Johnson Spine Osteoarthritis Pain Medicine Product Portfolio 6.2.5 Johnson and Johnson Recent Developments/Updates 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Corporation Information 6.3.2 GlaxoSmithKline Description and Business Overview 6.3.3 GlaxoSmithKline Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.3.4 GlaxoSmithKline Spine Osteoarthritis Pain Medicine Product Portfolio 6.3.5 GlaxoSmithKline Recent Developments/Updates 6.4 Bayer 6.4.1 Bayer Corporation Information 6.4.2 Bayer Description and Business Overview 6.4.3 Bayer Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bayer Spine Osteoarthritis Pain Medicine Product Portfolio 6.4.5 Bayer Recent Developments/Updates 6.5 Eli Lilly 6.5.1 Eli Lilly Corporation Information 6.5.2 Eli Lilly Description and Business Overview 6.5.3 Eli Lilly Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Eli Lilly Spine Osteoarthritis Pain Medicine Product Portfolio 6.5.5 Eli Lilly Recent Developments/Updates 6.6 Novartis 6.6.1 Novartis Corporation Information 6.6.2 Novartis Description and Business Overview 6.6.3 Novartis Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Novartis Spine Osteoarthritis Pain Medicine Product Portfolio 6.6.5 Novartis Recent Developments/Updates 6.7 Sanofi 6.6.1 Sanofi Corporation Information 6.6.2 Sanofi Description and Business Overview 6.6.3 Sanofi Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi Spine Osteoarthritis Pain Medicine Product Portfolio 6.7.5 Sanofi Recent Developments/Updates 6.8 Horizon Pharma 6.8.1 Horizon Pharma Corporation Information 6.8.2 Horizon Pharma Description and Business Overview 6.8.3 Horizon Pharma Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Horizon Pharma Spine Osteoarthritis Pain Medicine Product Portfolio 6.8.5 Horizon Pharma Recent Developments/Updates 6.9 Abbott 6.9.1 Abbott Corporation Information 6.9.2 Abbott Description and Business Overview 6.9.3 Abbott Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Abbott Spine Osteoarthritis Pain Medicine Product Portfolio 6.9.5 Abbott Recent Developments/Updates 6.10 Mylan 6.10.1 Mylan Corporation Information 6.10.2 Mylan Description and Business Overview 6.10.3 Mylan Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Mylan Spine Osteoarthritis Pain Medicine Product Portfolio 6.10.5 Mylan Recent Developments/Updates 6.11 Daiichi Sankyo 6.11.1 Daiichi Sankyo Corporation Information 6.11.2 Daiichi Sankyo Spine Osteoarthritis Pain Medicine Description and Business Overview 6.11.3 Daiichi Sankyo Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Daiichi Sankyo Spine Osteoarthritis Pain Medicine Product Portfolio 6.11.5 Daiichi Sankyo Recent Developments/Updates 6.12 TEVA 6.12.1 TEVA Corporation Information 6.12.2 TEVA Spine Osteoarthritis Pain Medicine Description and Business Overview 6.12.3 TEVA Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.12.4 TEVA Spine Osteoarthritis Pain Medicine Product Portfolio 6.12.5 TEVA Recent Developments/Updates 6.13 Almatica Pharma 6.13.1 Almatica Pharma Corporation Information 6.13.2 Almatica Pharma Spine Osteoarthritis Pain Medicine Description and Business Overview 6.13.3 Almatica Pharma Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Almatica Pharma Spine Osteoarthritis Pain Medicine Product Portfolio 6.13.5 Almatica Pharma Recent Developments/Updates 6.14 Astellas Pharma 6.14.1 Astellas Pharma Corporation Information 6.14.2 Astellas Pharma Spine Osteoarthritis Pain Medicine Description and Business Overview 6.14.3 Astellas Pharma Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Astellas Pharma Spine Osteoarthritis Pain Medicine Product Portfolio 6.14.5 Astellas Pharma Recent Developments/Updates 6.15 Tide Pharmaceutical 6.15.1 Tide Pharmaceutical Corporation Information 6.15.2 Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Description and Business Overview 6.15.3 Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Product Portfolio 6.15.5 Tide Pharmaceutical Recent Developments/Updates 6.16 Iroko Pharmaceuticals 6.16.1 Iroko Pharmaceuticals Corporation Information 6.16.2 Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Description and Business Overview 6.16.3 Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Product Portfolio 6.16.5 Iroko Pharmaceuticals Recent Developments/Updates 6.17 Hengrui Pharmaceutical 6.17.1 Hengrui Pharmaceutical Corporation Information 6.17.2 Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Description and Business Overview 6.17.3 Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Product Portfolio 6.17.5 Hengrui Pharmaceutical Recent Developments/Updates 6.18 Abiogen Pharma 6.18.1 Abiogen Pharma Corporation Information 6.18.2 Abiogen Pharma Spine Osteoarthritis Pain Medicine Description and Business Overview 6.18.3 Abiogen Pharma Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Abiogen Pharma Spine Osteoarthritis Pain Medicine Product Portfolio 6.18.5 Abiogen Pharma Recent Developments/Updates 7 Spine Osteoarthritis Pain Medicine Manufacturing Cost Analysis 7.1 Spine Osteoarthritis Pain Medicine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Spine Osteoarthritis Pain Medicine 7.4 Spine Osteoarthritis Pain Medicine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Spine Osteoarthritis Pain Medicine Distributors List 8.3 Spine Osteoarthritis Pain Medicine Customers 9 Spine Osteoarthritis Pain Medicine Market Dynamics 9.1 Spine Osteoarthritis Pain Medicine Industry Trends 9.2 Spine Osteoarthritis Pain Medicine Growth Drivers 9.3 Spine Osteoarthritis Pain Medicine Market Challenges 9.4 Spine Osteoarthritis Pain Medicine Market Restraints 10 Global Market Forecast 10.1 Spine Osteoarthritis Pain Medicine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Spine Osteoarthritis Pain Medicine by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Spine Osteoarthritis Pain Medicine by Type (2022-2027) 10.2 Spine Osteoarthritis Pain Medicine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Spine Osteoarthritis Pain Medicine by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Spine Osteoarthritis Pain Medicine by Application (2022-2027) 10.3 Spine Osteoarthritis Pain Medicine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Spine Osteoarthritis Pain Medicine by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Spine Osteoarthritis Pain Medicine by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Spine Osteoarthritis Pain Medicine Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Spine Osteoarthritis Pain Medicine Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Spine Osteoarthritis Pain Medicine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Spine Osteoarthritis Pain Medicine Covered in This Study Table 5. Global Spine Osteoarthritis Pain Medicine Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Spine Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2016-2021) Table 7. Global Spine Osteoarthritis Pain Medicine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Spine Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Spine Osteoarthritis Pain Medicine Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Spine Osteoarthritis Pain Medicine Manufacturing Sites and Area Served Table 11. Manufacturers Spine Osteoarthritis Pain Medicine Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Spine Osteoarthritis Pain Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spine Osteoarthritis Pain Medicine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Spine Osteoarthritis Pain Medicine Sales by Region (2016-2021) & (K Units) Table 16. Global Spine Osteoarthritis Pain Medicine Sales Market Share by Region (2016-2021) Table 17. Global Spine Osteoarthritis Pain Medicine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 19. North America Spine Osteoarthritis Pain Medicine Sales Market Share by Country (2016-2021) Table 20. North America Spine Osteoarthritis Pain Medicine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Spine Osteoarthritis Pain Medicine Revenue Market Share by Country (2016-2021) Table 22. Europe Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 23. Europe Spine Osteoarthritis Pain Medicine Sales Market Share by Country (2016-2021) Table 24. Europe Spine Osteoarthritis Pain Medicine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Spine Osteoarthritis Pain Medicine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Spine Osteoarthritis Pain Medicine Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Spine Osteoarthritis Pain Medicine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Spine Osteoarthritis Pain Medicine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Spine Osteoarthritis Pain Medicine Revenue Market Share by Region (2016-2021) Table 30. Latin America Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 31. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share by Country (2016-2021) Table 32. Latin America Spine Osteoarthritis Pain Medicine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Spine Osteoarthritis Pain Medicine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Spine Osteoarthritis Pain Medicine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Spine Osteoarthritis Pain Medicine Revenue Market Share by Country (2016-2021) Table 38. Global Spine Osteoarthritis Pain Medicine Sales (K Units) by Type (2016-2021) Table 39. Global Spine Osteoarthritis Pain Medicine Sales Market Share by Type (2016-2021) Table 40. Global Spine Osteoarthritis Pain Medicine Revenue (Million US$) by Type (2016-2021) Table 41. Global Spine Osteoarthritis Pain Medicine Revenue Share by Type (2016-2021) Table 42. Global Spine Osteoarthritis Pain Medicine Price (USD/Unit) by Type (2016-2021) Table 43. Global Spine Osteoarthritis Pain Medicine Sales (K Units) by Application (2016-2021) Table 44. Global Spine Osteoarthritis Pain Medicine Sales Market Share by Application (2016-2021) Table 45. Global Spine Osteoarthritis Pain Medicine Revenue (Million US$) by Application (2016-2021) Table 46. Global Spine Osteoarthritis Pain Medicine Revenue Share by Application (2016-2021) Table 47. Global Spine Osteoarthritis Pain Medicine Price (USD/Unit) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Pfizer Spine Osteoarthritis Pain Medicine Product Table 52. Pfizer Recent Developments/Updates Table 53. Johnson and Johnson Corporation Information Table 54. Johnson and Johnson Description and Business Overview Table 55. Johnson and Johnson Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Johnson and Johnson Spine Osteoarthritis Pain Medicine Product Table 57. Johnson and Johnson Recent Developments/Updates Table 58. GlaxoSmithKline Corporation Information Table 59. GlaxoSmithKline Description and Business Overview Table 60. GlaxoSmithKline Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. GlaxoSmithKline Spine Osteoarthritis Pain Medicine Product Table 62. GlaxoSmithKline Recent Developments/Updates Table 63. Bayer Corporation Information Table 64. Bayer Description and Business Overview Table 65. Bayer Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Bayer Spine Osteoarthritis Pain Medicine Product Table 67. Bayer Recent Developments/Updates Table 68. Eli Lilly Corporation Information Table 69. Eli Lilly Description and Business Overview Table 70. Eli Lilly Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Eli Lilly Spine Osteoarthritis Pain Medicine Product Table 72. Eli Lilly Recent Developments/Updates Table 73. Novartis Corporation Information Table 74. Novartis Description and Business Overview Table 75. Novartis Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Novartis Spine Osteoarthritis Pain Medicine Product Table 77. Novartis Recent Developments/Updates Table 78. Sanofi Corporation Information Table 79. Sanofi Description and Business Overview Table 80. Sanofi Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Sanofi Spine Osteoarthritis Pain Medicine Product Table 82. Sanofi Recent Developments/Updates Table 83. Horizon Pharma Corporation Information Table 84. Horizon Pharma Description and Business Overview Table 85. Horizon Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Horizon Pharma Spine Osteoarthritis Pain Medicine Product Table 87. Horizon Pharma Recent Developments/Updates Table 88. Abbott Corporation Information Table 89. Abbott Description and Business Overview Table 90. Abbott Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Abbott Spine Osteoarthritis Pain Medicine Product Table 92. Abbott Recent Developments/Updates Table 93. Mylan Corporation Information Table 94. Mylan Description and Business Overview Table 95. Mylan Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Mylan Spine Osteoarthritis Pain Medicine Product Table 97. Mylan Recent Developments/Updates Table 98. Daiichi Sankyo Corporation Information Table 99. Daiichi Sankyo Description and Business Overview Table 100. Daiichi Sankyo Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Daiichi Sankyo Spine Osteoarthritis Pain Medicine Product Table 102. Daiichi Sankyo Recent Developments/Updates Table 103. TEVA Corporation Information Table 104. TEVA Description and Business Overview Table 105. TEVA Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. TEVA Spine Osteoarthritis Pain Medicine Product Table 107. TEVA Recent Developments/Updates Table 108. Almatica Pharma Corporation Information Table 109. Almatica Pharma Description and Business Overview Table 110. Almatica Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Almatica Pharma Spine Osteoarthritis Pain Medicine Product Table 112. Almatica Pharma Recent Developments/Updates Table 113. Astellas Pharma Corporation Information Table 114. Astellas Pharma Description and Business Overview Table 115. Astellas Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Astellas Pharma Spine Osteoarthritis Pain Medicine Product Table 117. Astellas Pharma Recent Developments/Updates Table 118. Tide Pharmaceutical Corporation Information Table 119. Tide Pharmaceutical Description and Business Overview Table 120. Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Product Table 122. Tide Pharmaceutical Recent Developments/Updates Table 123. Iroko Pharmaceuticals Corporation Information Table 124. Iroko Pharmaceuticals Description and Business Overview Table 125. Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Product Table 127. Iroko Pharmaceuticals Recent Developments/Updates Table 128. Hengrui Pharmaceutical Corporation Information Table 129. Hengrui Pharmaceutical Description and Business Overview Table 130. Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Product Table 132. Hengrui Pharmaceutical Recent Developments/Updates Table 133. Abiogen Pharma Corporation Information Table 134. Abiogen Pharma Description and Business Overview Table 135. Abiogen Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Abiogen Pharma Spine Osteoarthritis Pain Medicine Product Table 137. Abiogen Pharma Recent Developments/Updates Table 138. Production Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Spine Osteoarthritis Pain Medicine Distributors List Table 141. Spine Osteoarthritis Pain Medicine Customers List Table 142. Spine Osteoarthritis Pain Medicine Market Trends Table 143. Spine Osteoarthritis Pain Medicine Growth Drivers Table 144. Spine Osteoarthritis Pain Medicine Market Challenges Table 145. Spine Osteoarthritis Pain Medicine Market Restraints Table 146. Global Spine Osteoarthritis Pain Medicine Sales Forecast by Type (2022-2027) & (K Units) Table 147. Global Spine Osteoarthritis Pain Medicine Sales Market Share Forecast by Type (2022-2027) Table 148. Global Spine Osteoarthritis Pain Medicine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 149. Global Spine Osteoarthritis Pain Medicine Revenue Market Share Forecast by Type (2022-2027) Table 150. Global Spine Osteoarthritis Pain Medicine Sales Forecast by Application (2022-2027) & (K Units) Table 151. Global Spine Osteoarthritis Pain Medicine Sales Market Share Forecast by Application (2022-2027) Table 152. Global Spine Osteoarthritis Pain Medicine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 153. Global Spine Osteoarthritis Pain Medicine Revenue Market Share Forecast by Application (2022-2027) Table 154. Global Spine Osteoarthritis Pain Medicine Sales Forecast by Region (2022-2027) & (K Units) Table 155. Global Spine Osteoarthritis Pain Medicine Sales Market Share Forecast by Region (2022-2027) Table 156. Global Spine Osteoarthritis Pain Medicine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 157. Global Spine Osteoarthritis Pain Medicine Revenue Market Share Forecast by Region (2022-2027) Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Spine Osteoarthritis Pain Medicine Figure 2. Global Spine Osteoarthritis Pain Medicine Market Share by Type in 2020 & 2027 Figure 3. Oral Product Picture Figure 4. Injection Product Picture Figure 5. External Product Picture Figure 6. Global Spine Osteoarthritis Pain Medicine Market Share by Application in 2020 & 2027 Figure 7. Medical Care Figure 8. Personal Care Figure 9. Global Spine Osteoarthritis Pain Medicine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Spine Osteoarthritis Pain Medicine Market Size 2016-2027 (US$ Million) Figure 11. Global Spine Osteoarthritis Pain Medicine Sales 2016-2027 (K Units) Figure 12. Global Spine Osteoarthritis Pain Medicine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Spine Osteoarthritis Pain Medicine Sales Share by Manufacturers in 2020 Figure 14. Global Spine Osteoarthritis Pain Medicine Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Spine Osteoarthritis Pain Medicine Players: Market Share by Revenue in 2020 Figure 16. Spine Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Spine Osteoarthritis Pain Medicine Sales Market Share by Region (2016-2021) Figure 18. Global Spine Osteoarthritis Pain Medicine Sales Market Share by Region in 2020 Figure 19. Global Spine Osteoarthritis Pain Medicine Revenue Market Share by Region (2016-2021) Figure 20. Global Spine Osteoarthritis Pain Medicine Revenue Market Share by Region in 2020 Figure 21. U.S. Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Spine Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Spine Osteoarthritis Pain Medicine by Type (2016-2021) Figure 46. Sales Market Share of Spine Osteoarthritis Pain Medicine by Application (2016-2021) Figure 47. Sales Market Share of Spine Osteoarthritis Pain Medicine by Application in 2020 Figure 48. Revenue Share of Spine Osteoarthritis Pain Medicine by Application (2016-2021) Figure 49. Revenue Share of Spine Osteoarthritis Pain Medicine by Application in 2020 Figure 50. Manufacturing Cost Structure of Spine Osteoarthritis Pain Medicine Figure 51. Manufacturing Process Analysis of Spine Osteoarthritis Pain Medicine Figure 52. Spine Osteoarthritis Pain Medicine Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Pfizer Johnson and Johnson GlaxoSmithKline Bayer Eli Lilly Novartis Sanofi Horizon Pharma Abbott Mylan Daiichi Sankyo TEVA Almatica Pharma Astellas Pharma Tide Pharmaceutical Iroko Pharmaceuticals Hengrui Pharmaceutical Abiogen Pharma